Heska (HSKA) Short-Term Debt & Capital Lease Obligation : $4.0 Mil (As of Mar. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Heska Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Heska's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $4.0 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Heska's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was $105.4 Mil.

Heska Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Heska's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heska Short-Term Debt & Capital Lease Obligation Chart

Heska Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

1.75

2.09

2.23

2.94

Heska Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															2.50	2.55	2.68	2.94	4.05

Heska Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Heska Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Heska's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Heska (HSKA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heska Corp (NAS:HSKA) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

AHCO SILK AVNS UFPT FNA PRCT SIBN CTKB OM TMCI ABT MDT SYK BSX EW SZSE:300760 DXCM ZBH ALGN STE

Traded in Other Exchanges

N/A

Address

3760 Rocky Mountain Avenue, Loveland, CO, USA, 80538

Website

https://www.heska.com

Heska Corp is engaged in developing, manufacturing, marketing, selling, and supporting veterinary products. The company's products include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products; and practice information management software and related software. It operates through two segments North America and International. The Company's core strategic focus on Point of Care laboratory and imaging products is included in both segments.

Executives

Joachim A. Hasenmaier	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Robert L Antin	director
Mark F Furlong	director	770 M WATER ST, MILWAUKEE WI 53202
Stephen L Davis	director	2901 BUTTERFIELD ROAD, OAK BROOK IL 60523
Providenti Anthony C. Jr.	officer: EVP, Corporate Development	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Kevin S. Wilson	officer: President and COO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Eleanor F. Baker	officer: EVP, Managing Dir. & COO, scil	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Christopher D. Sveen	officer: CAO & General Counsel	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Nancy Wisnewski	officer: EVP, Prod. Dev. & Cust. Supp	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Sharon L. Riley	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Catherine Grassman	officer: EVP, CFO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason D Aroesty	officer: EVP, International Diagnostics	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Bonnie J. Trowbridge	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Scott Humphrey	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason A Napolitano	officer: Exec. VP, CFO & Secretary	1613 PROSPECT PARKWAY, FORT COLLINS CO 80525